A Multicenter, Randomized, Double-Blind, Parallel-Group Study To Assess The Efficacy And Safety Of Oral Etrasimod As Induction And Maintenance Therapy For Moderately To Severely Active Crohn’S Disease
Posted Date: Sep 21, 2021
- Investigator: Loren Brook
- Type of Study: Drug
This study is to evaluate the efficacy and safety of Etrasimod in subjects with moderate to severe Crohn's Disease.
Age 18-80. Diagnosis Of Crohn's Disease For At Least 3 Months Prior To Screening. Willing And Able To Comply With Procedures Required In The Protocol.
Crohn's, Crohn's Disease
For More Information: